Whoop faces suit over tech in health tracker watch ...

LSIPR sister title releases USA Patents Rankings, divided into categories of non-contentious and contentious work | Listing ...

Oral hearings heard the USPTO side with MSD (Merck) over a term extension for a reissued patent, in a case set to have huge implications for pharma market exclusivity, reports Marisa Woutersen.

29 August 2024 Regeneron accused the Swiss pharma company of infringing a slew of patents related to Eylea and violating the ...

Former DLA Piper partner Melissa Harwood joins firm’s chemistry and life sciences team | Brings experience in biotechnology, therapeutics, and chemical industries. If you don't have a login or your ...

Complex legal battle concerns ‘skinny label’ strategy used by generic drug makers, prompting a $235 million award | Pharma ...

Teva insisted panel’s narrow interpretation of ‘claims the drug’ will have a seismic effect on the Orange Book | Stay granted while en banc rehearing is under question | Decision could reshape patent ...

15 February 2024 Judge says UK courts should depart from a European precedent following Brexit | MSD counsel says appeal had ...

Five-strong team to open new location in the spring | Office will be led by experienced litigators and patent specialists ...

In an exclusive interview, the One IPO Search project lead explains how a change in mindset at the office helped ‘unlock the value’ of UK patent data.

‘Distinguished’ litigator Coke Morgan Stewart takes her place as deputy and interim director of the US Patent and Trademark Office, where she was formerly employed for a decade.

Will this year be defined by a concerted shift towards ‘One Health’? Simon Kiddle and Rebecca Tollervey of Mewburn Ellis explore.